MXCT
MXCT
NASDAQ · Life Sciences Tools & Services

Maxcyte Inc

$0.81
+0.00 (+0.00%)
As of Feb 8, 2:13 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 12.86M 11.59M 9.98M
Net Income 759.2K 913.3K 656.0K
EPS
Profit Margin 5.9% 7.9% 6.6%
Rev Growth +21.5% +8.1% +21.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 20.99M 17.20M 19.69M
Total Equity 38.44M 38.88M 41.65M
D/E Ratio 0.55 0.44 0.47
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.61M 1.25M 1.22M
Free Cash Flow 506.3K 402.0K 324.3K